Cargando…

MALAT1 predicts poor survival in osteosarcoma patients and promotes cell metastasis through associating with EZH2

Osteosarcoma is the most common type of bone cancer, especially in children and young adults. Recently, long noncoding RNAs (lncRNAs) have emerged as new prognostic markers and gene regulators in several cancers, including osteosarcoma. In this study, we investigated the contributions of the lncRNA...

Descripción completa

Detalles Bibliográficos
Autores principales:	Huo, Yanqing, Li, Qingbo, Wang, Xiqian, Jiao, Xiejia, Zheng, Jiachun, Li, Zhiqiang, Pan, Xiaohan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2017
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5564539/ https://www.ncbi.nlm.nih.gov/pubmed/28388584 http://dx.doi.org/10.18632/oncotarget.16551

Ejemplares similares

Long noncoding RNA MALAT1 promotes cell proliferation through suppressing miR-205 and promoting SMAD4 expression in osteosarcoma
por: Li, Qingbo, et al.
Publicado: (2017)

Prognostic implication of cuproptosis related genes associates with immunity in Ewing's sarcoma
por: Li, Qingbo, et al.
Publicado: (2023)

LncRNA MALAT1 promotes development of mantle cell lymphoma by associating with EZH2
por: Wang, Xin, et al.
Publicado: (2016)

Minimally invasive versus open surgery for acute Achilles tendon rupture: a systematic review of overlapping meta-analyses
por: Li, Qingbo, et al.
Publicado: (2016)

Retraction Note: minimally invasive versus open surgery for acute Achilles tendon rupture: a systematic review of overlapping meta-analyses
por: Li, Qingbo, et al.
Publicado: (2018)

LncRNA MALAT1 facilitates lung metastasis of osteosarcomas through miR-202 sponging
por: Zhang, Jun, et al.
Publicado: (2020)

BMPR2 expression level is correlated with low immune infiltration and predicts metastasis and poor survival in osteosarcoma
por: Cao, Hongxin, et al.
Publicado: (2021)

MALAT1 promotes osteosarcoma development by targeting TGFA via MIR376A
por: Luo, Wei, et al.
Publicado: (2016)

LncRNA MALAT1 promotes growth and metastasis of head and neck squamous cell carcinoma by repressing VHL through a non-canonical function of EZH2
por: Duan, Yuansheng, et al.
Publicado: (2023)

EZH2 promotes cell migration and invasion but not alters cell proliferation by suppressing E-cadherin, partly through association with MALAT-1 in pancreatic cancer
por: Han, Ting, et al.
Publicado: (2016)

MALAT1-mediated EZH2 Recruitment to the GFER Promoter Region Curbs Normal Hepatocyte Proliferation in Acute Liver Injury
por: Chen, Li, et al.
Publicado: (2023)

Correction: LncRNA MALAT1 promotes growth and metastasis of head and neck squamous cell carcinoma by repressing VHL through a non-canonical function of EZH2
por: Duan, Yuansheng, et al.
Publicado: (2023)

Overexpression of EZH2 is associated with the poor prognosis in osteosarcoma and function analysis indicates a therapeutic potential
por: Sun, Ranran, et al.
Publicado: (2016)

Long non-coding RNA MALAT1 for promoting metastasis and proliferation by acting as a ceRNA of miR-144-3p in osteosarcoma cells
por: Wang, Yong, et al.
Publicado: (2017)

YY1 overexpression is associated with poor prognosis and metastasis-free survival in patients suffering osteosarcoma
por: Nigris, Filomena de, et al.
Publicado: (2011)

Long noncoding RNA MALAT1 promotes malignant development of esophageal squamous cell carcinoma by targeting β-catenin via Ezh2
por: Wang, Wei, et al.
Publicado: (2016)

PKIB involved in the metastasis and survival of osteosarcoma
por: Wan, Rongxue, et al.
Publicado: (2022)

MALAT-1 is Associated with the Doxorubicin Resistance in U-2OS Osteosarcoma Cells
por: Liu, Chang, et al.
Publicado: (2021)

lncRNA MALAT1 promotes cell proliferation and invasion by regulating the miR-101/EZH2 axis in oral squamous cell carcinoma
por: Xiao, Lei, et al.
Publicado: (2020)

LncRNA MALAT1 enhances oncogenic activities of EZH2 in castration-resistant prostate cancer
por: Wang, Dejie, et al.
Publicado: (2015)

TUFT1 Promotes Osteosarcoma Cell Proliferation and Predicts Poor Prognosis in Osteosarcoma Patients
por: Yu, Yao-Ping, et al.
Publicado: (2018)

TRA2A Binds With LncRNA MALAT1 To Promote Esophageal Cancer Progression By Regulating EZH2/β-catenin Pathway
por: Zhao, Xing, et al.
Publicado: (2021)

CSE1L interaction with MSH6 promotes osteosarcoma progression and predicts poor patient survival
por: Cheng, Dong-dong, et al.
Publicado: (2017)

Cyclooxygeanse-2 promotes metastasis in osteosarcoma
por: Qu, Liyan, et al.
Publicado: (2015)

MALAT1 long ncRNA promotes gastric cancer metastasis by suppressing PCDH10
por: Qi, Ying, et al.
Publicado: (2016)

TUG1 promotes osteosarcoma tumorigenesis by upregulating EZH2 expression via miR-144-3p
por: Cao, Jiaqing, et al.
Publicado: (2017)

Long non-coding RNA metastasis associated in lung adenocarcinoma transcript 1 (MALAT1) interacts with estrogen receptor and predicted poor survival in breast cancer
por: Huang, Nai-si, et al.
Publicado: (2016)

CBX2 and EZH2 cooperatively promote the growth and metastasis of lung adenocarcinoma
por: Hu, Fei-Fei, et al.
Publicado: (2021)

EZH2–CCF–cGAS Axis Promotes Breast Cancer Metastasis
por: Duan, Dandan, et al.
Publicado: (2022)

Overexpression of Notch3 is associated with metastasis and poor prognosis in osteosarcoma patients
por: Tang, Xue-Feng, et al.
Publicado: (2019)

Calponin 3 is associated with poor prognosis and regulates proliferation and metastasis in osteosarcoma
por: Dai, Fei, et al.
Publicado: (2020)

A risk score model for the prediction of osteosarcoma metastasis
por: Dong, Siqi, et al.
Publicado: (2019)

FBX8 Acts as an Invasion and Metastasis Suppressor and Correlates with Poor Survival in Hepatocellular Carcinoma
por: Wang, Feifei, et al.
Publicado: (2013)

Expression of EZH2 is associated with poor outcome in colorectal cancer
por: Chen, Zhuanpeng, et al.
Publicado: (2018)

Decreased long non‐coding RNA lincFOXF1 indicates poor progression and promotes cell migration and metastasis in osteosarcoma
por: Yang, Shengquan, et al.
Publicado: (2020)

SIRT1 promotes metastasis of human osteosarcoma cells
por: Zhang, Ning, et al.
Publicado: (2016)

PROSER2 is a poor prognostic biomarker for patients with osteosarcoma and promotes proliferation, migration and invasion of osteosarcoma cells
por: Li, Zhengjiang, et al.
Publicado: (2022)

Downregulation of CD99 and upregulation of human leukocyte antigen class II promote tumor aggravation and poor survival in patients with osteosarcomas
por: Zhou, Quan, et al.
Publicado: (2014)

RUFY3 Predicts Poor Prognosis and Promotes Metastasis through Epithelial-mesenchymal Transition in Lung Adenocarcinoma
por: Men, Wanfu, et al.
Publicado: (2019)

SEPT2 crotonylation promotes metastasis and recurrence in hepatocellular carcinoma and is associated with poor survival
por: Zhang, Xin-yue, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_3apgnsn49jfbe0hqfsdh3m09gh